The SNP rs13118664 is an intron variant of the hydroxysteroid 17-beta dehydrogenase 13 (HSD17B13) gene, and its variant has been reported to be associated with a lower risk of NAFLD and incidences of adverse liver outcomes (Ting et al., 2021; Hudert et al., 2022). This evidence concerns the gene HSD17B13 and metabolic dysfunction-associated steatotic liver disease.